| Aug 9 |
Do Analysts Think That Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Is a Good GLP-1 and Weight Loss Stock to Invest In?
|
| Aug 8 |
Biohaven Reports Second Quarter 2024 Financial Results and Recent Business Developments
|
| Jul 26 |
Biohaven: Taldefgrobep Alfa Might Have A Place Beyond SMA Treatment
|
| Jul 24 |
Morgan Stanley starts Biohaven at overweight, cites broad pipeline
|
| Jul 22 |
$1M Bet On Biohaven? Check Out These 3 Stocks Insiders Are Buying
|
| May 29 |
Biohaven Stock Stumbles As Protein-Degrading Drug Falls Short Of Expectations In Early-Stage Study
|
| May 29 |
Biohaven stock falls 30% premarket amid drug updates
|
| May 29 |
Biohaven Showcases Broad Innovative Portfolio and Pipeline Updates Across Multiple Therapeutic Areas including Immunology, Neuroscience, Metabolic Disorders and Oncology at Annual Investor R&D Day
|
| May 29 |
Biohaven Doses First Patient with its Novel Trop-2 Directed Antibody Drug Conjugate (ADC) BHV-1510 in Advanced or Metastatic Epithelial Tumors
|
| May 22 |
This Biotech Stock Is Poised For 80% Upside With Breakthrough In Obesity Drug Market, Says JPMorgan
|
